Coronary artery bypass graft surgery remains the standard of care for patients with diabetes.
Coronary artery bypass graft surgery (CABG) and percutaneous coronary intervention (PCI) are proven effective treatments of coronary artery disease (CAD), however, the optimal revascularization strategy remains unclear in certain patient subsets. The recently published "Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM)" trial is a randomized study evaluating the use of CABG vs PCI in diabetic patients with multivessel coronary disease. The purpose of this editorial is to review the FREEDOM trial and the available literature guiding clinicians to make evidence-based decisions when treating diabetic patients with multivessel coronary disease. The current evidence suggests that CABG should remain the standard of care for this patient population.
Department of Cardiothoracic Surgery, Emory University school of Medicine, Atlanta, Georgia.
Emmanuel
E
Moss
Mahboob
M
Alam
Christie M
CM
Ballantyne
John D
JD
Puskas
D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000592:standards*; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000601:surgery*; D003925:Diabetic Angiopathies / Q000175:diagnosis / Q000601:surgery*; D019317:Evidence-Based Medicine; D006801:Humans; D018579:Patient Selection; D062645:Percutaneous Coronary Intervention; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D059039:Standard of Care / Q000592:standards*; D016896:Treatment Outcome
CABG; Coronary artery disease; Diabetes; PCI